Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 7, 2023
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
[ Mon, Aug 07th 2023
] - WOPRAI
Dan Leonard Maintained (BIO) at Buy with Decreased Target to $525 on, Aug 7th, 2023
Dan Leonard of Wells Fargo, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Decreased Target from $550 to $525 on, Aug 7th, 2023.
Dan has made no other calls on BIO in the last 4 months.
There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 0 agree with Dan's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Dan
- Conor McNamara of "RBC Capital" Maintained at Buy with Increased Target to $524 on, Friday, August 4th, 2023
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $525 on, Monday, May 8th, 2023
